| MERUS N.V. EO -,09 |
| Niederlande |
| Gesundheit |
| NL0011606264 / A2AKFX |
| 2GH (Frankfurt) / MRUS (NASDAQ) |
| FRA:2GH, ETR:2GH, 2GH:GR, NASDAQ:MRUS |
| - |
| https://merus.nl/ |
|
Merus N.V. is a clinical-stage biopharmaceutical c..
>Volltext.. |
| 6243.82 Mio. EUR |
| 5712.16 Mio. EUR |
| 48.08 Mio. EUR |
| -313.26 Mio. EUR |
| -323.76 Mio. EUR |
| -4.53 EUR |
| 10.46 Mio. EUR |
| 312.17 Mio. EUR |
| -276.05 Mio. EUR |
| 7.33 |
| 49.48% |
| -47.87% |
| - |
| - |
| - |
| MERUS |
| 30.12.25 |
|